The FDA has granted Spino Modulation (a Spinologics subsidiary) a “Breakthrough Device Designation” for our MIScoli(TM) system
Recent Posts
-
Cervision™ – First International Sales Launch in
January 26, 2022 -
Meet the Awardees of the 2021 NFL
December 2, 2021 -
With computational modeling & simulation, product development
November 17, 2021